Header cover image
  • Investing Ideas
  • /
  • Belgian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Belgian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

1

0 new

High return on equity, past performance and sound balance sheet.

1 companies

argenx

Market Cap: €46.1b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

ARGX

€753.20

7D

-2.3%

1Y

29.7%